Prequalification for Pharmaceutical Manufacturers and Sole Agents for Fiscal Year 2026-27

The Pakistan Water and Power Development Authority (WAPDA) Medical Directorate Lahore is inviting applications for prequalification of pharmaceutical manufacturers and sole agents of foreign manufacturers for the fiscal year 2026-27. This procurement is specifically for the supply of drugs and medicines under a closed framework agreement. The medicines will be delivered free of cost to consignee’s end, which includes various procuring agencies operating under the technical and administrative control of WAPDA Medical Directorate in Lahore. The prequalification process requires firms to be registered with the income tax and sales tax departments and be active taxpayers listed on the FBR Active Taxpayer List (ATL). Eligible licensed and registered firms can participate through the Electronic Procurement and Disposal System (EPADS) version 1.0. The scope includes a comprehensive range of pharmaceutical products to meet the medical needs of WAPDA’s healthcare facilities. Applicants must submit their electronic applications via EPADS by 12th May 2026 at 11:00 AM. Manual submissions will not be accepted. The technical and financial bids will be opened electronically on the same day at 11:30 AM. Interested bidders should ensure they have valid PEC registration if applicable, and maintain all relevant tax documentation and experience certificates to comply with eligibility criteria. A practical tip for bidders is to carefully review the prequalification documents available on www.eprocure.gov.pk and www.ppra.org.pk to understand the detailed terms and conditions. Early submission through EPADS is recommended to avoid last-minute technical issues. This tender offers a significant opportunity for pharmaceutical suppliers to establish a long-term supply relationship with a major government medical directorate.